Floatz logo

PITTSBURGH COMPOUND B UNLABELLED

Vascular Cognitive Impairment

National Taiwan University HospitalSmall moleculePhase 4 / ApprovedActive
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Vascular Cognitive Impairment cohort.

Asset / SponsorPhaseRating
Risperdal
Janssen-Cilag Pty Ltd
Phase 3BB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Peking University First Hospital
Phase 4BB
OXYCODONE HYDROCHLORIDE, HYDROCODONE-
VA Office of Research and Development
Phase 4BB
Acetylsalicylic Acid
Peking University First Hospital
Phase 4BB
Rivastigmine
Novartis
Phase 3BB

View all 42 →

Same molecule, other indications

PITTSBURGH COMPOUND B UNLABELLED is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
65 / 100
View asset →
vascular dementiaDormant
BB
Indicative ·
65 / 100
View asset →
frontotemporal dementiaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →